Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Singclean Anti-adhesion Technology With Professor Osama Shawki Shines at FIGO 2025-10-13 13:00
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
Smartee Launches World's First Sleep Aligner Combining Anti-Snoring Therapy with Teeth Alignment 2025-10-13 09:38
Everest Medicines Announces NMPA Approval of IND Application for Tumor-Associated Antigen Cancer Vaccine EVM14 2025-10-13 08:47
Ascletis Selects a Best-In-Class Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for Clinical Development 2025-10-13 08:10
Reach Surgical's OMNIBOT Performs First Urology Robotic Telesurgeries in Latin America 2025-10-13 08:00
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001 2025-10-11 20:45
Sandstone Easydrip™ Plus Pen Needles Debut in Turkey -- Patent‑Protected Hexagonal Hub for Comfort and Control 2025-10-11 15:50
Circulation Publishes 6-Month Outcomes from First-in-Human VCAS Trial of FieldForce™ Pulsed Field Ablation System: 82% Freedom from VT/VF Recurrence and 98% Reduction in Burden 2025-10-11 04:35
Berlin Heals Holding AG Successfully Completes Enrollment in Phase I of the CMIC-III Less Invasive Study 2025-10-10 15:00
Health in Your Hands? Asia's Top Health Experts Say 'Yes' and Reveal How 2025-10-10 14:43
Renalys Announces Completion of Primary Endpoint Data Collection for Phase III Clinical Trial of Sparsentan for Iga Nephropathy in Japan 2025-10-10 14:00
IHH Healthcare launches Global Incubator to fuel game-changing innovation 2025-10-10 13:09
WuXi Biologics Receives MSCI AAA ESG Rating for Third Consecutive Year 2025-10-10 08:30
Celltrion receives U.S. FDA approval for EYDENZELT® (aflibercept-boav), biosimilar referencing EYLEA® (aflibercept) 2025-10-10 06:56
Alamar Biosciences Launches NULISAqpcr™ BD-pTau217 Assay: A Breakthrough in Non-Invasive, Brain-Specific Biomarker Detection for Alzheimer's Disease Research 2025-10-10 05:23
POMDOCTOR LIMITED Announces Closing of Initial Public Offering 2025-10-10 04:05
Lifespan-Backed Algen Biotechnologies Partners with AstraZeneca to Advance AI Drug Discovery 2025-10-09 23:09
LuX-Valve Plus Approved for Hong Kong-Macao Medicine and Equipment Connect 2025-10-09 21:00
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission 2025-10-09 20:50
1 27 28 29 30 31 1098